In vitro and in vivo evaluation of the antimicrobial, antioxidant, cytotoxic, hemolytic activities and in silico POM/DFT/DNA-binding and pharmacokinetic analyses of new sulfonamide bearing thiazolidin-4-ones

化学 溶血 立体化学 细胞毒性 生物信息学 抗菌剂 体内 抗氧化剂 对接(动物) 组合化学 席夫碱 分子模型 体外 有机化学 生物化学 生物 护理部 生物技术 免疫学 基因 医学
作者
Sangar Ali Hassan,Dara Muhammed Aziz,Media Noori Abdullah,Ajmal R. Bhat,Rajendra S. Dongre,Taîbi Ben Hadda,Faisal A. Almalki,Sarkar M. A. Kawsar,A. Kalilur Rahiman,Sumeer Ahmed,Magda H. Abdellattif,Malika Berredjem,Sheema Sheikh,Joazaizulfazli Jamalis
出处
期刊:Journal of Biomolecular Structure & Dynamics [Informa]
卷期号:: 1-17 被引量:13
标识
DOI:10.1080/07391102.2023.2226713
摘要

In this work, Schiff bases and Thiazolidin-4-ones, were synthesized using Sonication and Microwave techniques, respectively. The Schiff base derivatives (3a–b) were synthesized via the reaction of Sulfathiazole (1) with benzaldehyde derivatives (2a–b), followed by the synthesis of 4-thiazoledinone (4a–b) derivatives by cyclizing the synthesized Schiff bases through thioglycholic acid. All the synthesized compounds were characterized by spectroscopic techniques such as FT IR, NMR and HRMS. The synthesized compounds were tested for their in vitro antimicrobial and antioxidant and in vivo cytotoxicity and hemolysis ability. The synthesized compounds displayed better antimicrobial and antioxidant activity and low toxicity in comparison to reference drugs and negative controls, respectively. The hemolysis test revealed the compounds exhibit lower hemolytic effects and hemolytic values are comparatively low and the safety of compounds is in comparison with standard drugs. Theoretical calculations were carried out by using the molecular operating environment (MOE) and Gaussian computing software and observations were in good agreement with the in vitro and in vivo biological activities. Petra/Osiris/Molinspiration (POM) results indicate the presence of three combined antibacterial, antiviral and antitumor pharmacophore sites. The molecular docking revealed the significant binding affinities and non-bonding interactions between the compounds and Erwinia Chrysanthemi (PDB ID: 1SHK). The molecular dynamics simulation under in silico physiological conditions revealed a stable conformation and binding pattern in a stimulating environment. HighlightsNew series of Thaiazolidin-4-one derivatives have been synthesized.Sonication and microwave techniques are used.Antimicrobial, Antioxidant, cytotoxicity, and hemolysis activities were observed for all synthesized compounds.Molecular Docking and DFT/POM analyses have been predicted.Communicated by Ramaswamy H. Sarma
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
zzz完成签到 ,获得积分10
1秒前
Sygganggang完成签到,获得积分10
2秒前
太叔丹翠发布了新的文献求助10
3秒前
4秒前
Aow完成签到,获得积分10
4秒前
5秒前
5秒前
碧蓝惜萱完成签到,获得积分10
5秒前
123发布了新的文献求助10
5秒前
打工鼠鼠完成签到,获得积分10
7秒前
8秒前
liuliuliu发布了新的文献求助30
8秒前
整齐凌萱发布了新的文献求助10
10秒前
Huang发布了新的文献求助10
10秒前
anling发布了新的文献求助10
10秒前
优雅山柏发布了新的文献求助10
11秒前
11秒前
太叔丹翠完成签到,获得积分10
12秒前
hchen发布了新的文献求助10
12秒前
12秒前
彩色惜文发布了新的文献求助10
15秒前
小马甲应助anling采纳,获得10
16秒前
tombulibo发布了新的文献求助10
17秒前
万能图书馆应助huyang采纳,获得10
17秒前
17秒前
周芷卉发布了新的文献求助10
18秒前
满意沛槐发布了新的文献求助10
19秒前
19秒前
HFELL完成签到,获得积分10
20秒前
鹏程完成签到 ,获得积分10
20秒前
自由的凌雪完成签到,获得积分10
21秒前
程之杭发布了新的文献求助10
21秒前
23秒前
23秒前
23秒前
tx完成签到,获得积分10
24秒前
科研通AI2S应助QQQQ采纳,获得10
24秒前
至乐无乐发布了新的文献求助10
24秒前
25秒前
高分求助中
Sustainability in Tides Chemistry 2800
Kinetics of the Esterification Between 2-[(4-hydroxybutoxy)carbonyl] Benzoic Acid with 1,4-Butanediol: Tetrabutyl Orthotitanate as Catalyst 1000
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
Very-high-order BVD Schemes Using β-variable THINC Method 568
Chen Hansheng: China’s Last Romantic Revolutionary 500
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3138888
求助须知:如何正确求助?哪些是违规求助? 2789815
关于积分的说明 7792820
捐赠科研通 2446185
什么是DOI,文献DOI怎么找? 1300930
科研通“疑难数据库(出版商)”最低求助积分说明 626066
版权声明 601079